Global Pen Needles Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
"Global Pen Needles Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global pen needles market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global pen needles market report has been segmented on the type, needle length, therapy, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Pen needles use injection pens to deliver medicine into the body which is an alternative drug delivery method to the vial and syringe. Pen needles are available in various sizes and are used by patients in various therapy which includes insulin, GLP-1, and growth hormones.
Increasing incidence for diabetics is expected to be major factor driving growth of the global pen needles market over the forecast period. In addition, companies focusing on development of technological advancement products is in turn expected to fuel demand for pen needles thereby boosting growth of the target market over the forecast period. In addition, growing awareness regarding benefits associated with use of insulin pens over syringes and vials are factors expected to boost growth of the market over the forecast period.
However, availability of alternative drug delivery methods is expected to hamper growth of global pen needles market over the forecast period. In addition, availability of cheap and inferior quality products is some among the other factors is expected to limit growth of global target market over the forecast period.
Market in North America accounted for significant revenue share of the global pen needles market in terms of revenue contribution as compared to that of markets in other regions. Increasing adoption of advance technology coupled with rising incidence of needle stick injuries are expected to create demand for pen needles thereby boosting growth of the market in the region over the forecast period. In addition, presence of leading players in the market coupled with favorable reimbursement scenario are another factors expected to support growth of the global pen needles market over the forecast period.
Europe accounts for second-highest revenue share contribution to the global market, registering a share of XX.X%, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. In addition, the market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years. The markets in Latin America and Middle East & Africa are expected to register moderate growth rate in the global pen needles market over the forecast period.
Global pen needles market segmentation, by type:
- Standard Pen Needles
- Safety Pen Needles
Global pen needles market segmentation, by needle length:
Global pen needles market segmentation, by therapy:
- Growth Hormones
Global pen needles market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Becton, Dickinson and Company
- Novo Nordisk A/S
- Ypsomed Holding AG
- Owen Mumford, Ltd.
- HTL-Strefa S.A.
- Braun Melsungen
- Terumo Corporation
- Ultimed, Inc. (LDI, Ltd.)
- Allison Medical, Inc.
- Artsana S.P.A.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!